SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5tvj'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DZ8_A_CAMA503_0 (CYTOCHROME P450-CAM)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 9	PHE A 402 THR A 79 LEU A 69 GLY A 188 THR A 135	None	1.47A	1dz8A-5tvjA: undetectable	1dz8A-5tvjA: 23.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DZ8_B_CAMB502_0 (CYTOCHROME P450-CAM)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 9	PHE A 402 THR A 79 LEU A 69 GLY A 188 THR A 135	None	1.49A	1dz8B-5tvjA: undetectable	1dz8B-5tvjA: 23.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DZ9_B_CAMB502_0 (CYTOCHROME P450-CAM)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 9	PHE A 402 THR A 79 LEU A 69 GLY A 188 THR A 135	None	1.46A	1dz9B-5tvjA: undetectable	1dz9B-5tvjA: 23.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FK6_A_LNLA1201_1 (NON-SPECIFIC LIPID TRANSFER PROTEIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 12	VAL A 71 ALA A 363 ALA A 134 LEU A 296 ALA A 116	None	1.00A	1fk6A-5tvjA: undetectable	1fk6A-5tvjA: 12.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GTN_J_TRPJ81_0 (TRP RNA-BINDING ATTENUATION PROTEIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	4 / 8	SER A 23 ALA A 22 GLY A 15 ALA A 21	None	0.66A	1gtnI-5tvjA: undetectable 1gtnJ-5tvjA: undetectable	1gtnI-5tvjA: 12.06 1gtnJ-5tvjA: 12.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LQT_A_ACTA1871_0 (FPRA)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	4 / 7	PHE A 84 ALA A 20 PHE A 27 PHE A 17	7LF A 502 (-4.0A) None None None	1.16A	1lqtA-5tvjA: undetectable	1lqtA-5tvjA: 25.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LQU_A_ACTA1428_0 (FPRA)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	4 / 7	PHE A 84 ALA A 20 PHE A 27 PHE A 17	7LF A 502 (-4.0A) None None None	1.17A	1lquA-5tvjA: undetectable	1lquA-5tvjA: 25.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RBP_A_RTLA183_0 (PLASMA RETINOL-BINDING PROTEIN PRECURSOR)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 12	ALA A 311 ALA A 391 ALA A 389 LEU A 382 GLN A 381	None	1.20A	1rbpA-5tvjA: undetectable	1rbpA-5tvjA: 17.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JN3_A_JN3A131_1 (FATTY ACID-BINDING PROTEIN, LIVER)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 12	THR A 398 VAL A 115 LEU A 77 THR A 79 PHE A 402	GOL A 503 (-3.9A) None None None None	1.20A	2jn3A-5tvjA: undetectable	2jn3A-5tvjA: 13.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OKC_B_SAMB500_1 (TYPE I RESTRICTION ENZYME STYSJI M PROTEIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	4 / 6	THR A 288 ARG A 286 ASP A 229 THR A 231	None	1.16A	2okcB-5tvjA: undetectable	2okcB-5tvjA: 21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OKC_B_SAMB500_1 (TYPE I RESTRICTION ENZYME STYSJI M PROTEIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	4 / 6	THR A 288 ARG A 286 THR A 231 ASP A 211	None	1.11A	2okcB-5tvjA: undetectable	2okcB-5tvjA: 21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QXS_A_RALA600_1 (ESTROGEN RECEPTOR)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 12	THR A 135 ALA A 363 LEU A 369 LEU A 296 PRO A 72	None	1.15A	2qxsA-5tvjA: undetectable	2qxsA-5tvjA: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XN7_A_T44A1355_1 (THYROXINE-BINDING GLOBULIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 10	LEU A 331 LEU A 321 LEU A 356 LEU A 305 ARG A 308	None	1.15A	2xn7A-5tvjA: undetectable 2xn7B-5tvjA: undetectable	2xn7A-5tvjA: 20.93 2xn7B-5tvjA: 7.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G1U_D_ADND438_1 (ADENOSYLHOMOCYSTEINA SE)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 12	LEU A 190 THR A 79 THR A 398 LEU A 361 PHE A 402	None None GOL A 503 (-3.9A) None None	1.27A	3g1uD-5tvjA: undetectable	3g1uD-5tvjA: 22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GWV_A_RFXA801_1 (TRANSPORTER)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 12	LEU A 383 ARG A 385 GLN A 381 ILE A 349 PHE A 317	None	1.03A	3gwvA-5tvjA: undetectable	3gwvA-5tvjA: 21.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WIP_G_ACHG301_0 (ACETYLCHOLINE-BINDIN G PROTEIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	4 / 8	TYR A 360 THR A 70 ARG A 183 LEU A 190	None CL A 504 (-3.8A) CL A 504 (-3.9A) None	1.18A	3wipG-5tvjA: undetectable 3wipH-5tvjA: undetectable	3wipG-5tvjA: 18.98 3wipH-5tvjA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DTZ_B_LDPB501_1 (CYTOCHROME P450 BM3 VARIANT 8C8)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	4 / 6	PHE A 402 ALA A 399 LEU A 294 THR A 398	None None None GOL A 503 (-3.9A)	1.11A	4dtzB-5tvjA: undetectable	4dtzB-5tvjA: 21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FGZ_B_CQAB302_0 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	4 / 8	GLU A 180 ARG A 242 GLY A 189 ARG A 183	None None CL A 504 (-4.7A) CL A 504 (-3.9A)	1.02A	4fgzA-5tvjA: undetectable 4fgzB-5tvjA: undetectable	4fgzA-5tvjA: 17.56 4fgzB-5tvjA: 17.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FZV_A_SAMA401_0 (PUTATIVE METHYLTRANSFERASE NSUN4)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 12	GLY A 160 GLY A 159 LEU A 218 GLY A 222 LEU A 252	None	1.08A	4fzvA-5tvjA: undetectable	4fzvA-5tvjA: 21.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4JD6_A_TOYA501_1 (ENHANCED INTRACELLULAR SURVIVAL PROTEIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	7 / 9	PHE A 24 ASP A 26 ILE A 28 TRP A 36 SER A 83 TYR A 126 GLU A 203	7LF A 502 ( 3.9A) 7LF A 502 (-3.5A) 7LF A 502 (-4.1A) 7LF A 502 (-3.9A) 7LF A 502 (-3.5A) COA A 501 (-4.0A) None	0.93A	4jd6A-5tvjA: 61.2	4jd6A-5tvjA: 98.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4JD6_A_TOYA501_1 (ENHANCED INTRACELLULAR SURVIVAL PROTEIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	7 / 9	PHE A 24 ASP A 26 ILE A 28 TRP A 36 SER A 83 VAL A 85 GLU A 203	7LF A 502 ( 3.9A) 7LF A 502 (-3.5A) 7LF A 502 (-4.1A) 7LF A 502 (-3.9A) 7LF A 502 (-3.5A) COA A 501 (-3.8A) None	0.62A	4jd6A-5tvjA: 61.2	4jd6A-5tvjA: 98.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4JD6_A_TOYA501_1 (ENHANCED INTRACELLULAR SURVIVAL PROTEIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	7 / 9	PHE A 24 ASP A 26 TRP A 36 SER A 83 VAL A 85 GLU A 203 GLU A 401	7LF A 502 ( 3.9A) 7LF A 502 (-3.5A) 7LF A 502 (-3.9A) 7LF A 502 (-3.5A) COA A 501 (-3.8A) None 7LF A 502 (-3.3A)	0.75A	4jd6A-5tvjA: 61.2	4jd6A-5tvjA: 98.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4JD6_B_TOYB501_1 (ENHANCED INTRACELLULAR SURVIVAL PROTEIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	7 / 9	PHE A 24 ASP A 26 ILE A 28 TRP A 36 SER A 83 TYR A 126 GLU A 203	7LF A 502 ( 3.9A) 7LF A 502 (-3.5A) 7LF A 502 (-4.1A) 7LF A 502 (-3.9A) 7LF A 502 (-3.5A) COA A 501 (-4.0A) None	0.90A	4jd6B-5tvjA: 61.2	4jd6B-5tvjA: 98.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4JD6_B_TOYB501_1 (ENHANCED INTRACELLULAR SURVIVAL PROTEIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	7 / 9	PHE A 24 ASP A 26 ILE A 28 TRP A 36 SER A 83 VAL A 85 GLU A 203	7LF A 502 ( 3.9A) 7LF A 502 (-3.5A) 7LF A 502 (-4.1A) 7LF A 502 (-3.9A) 7LF A 502 (-3.5A) COA A 501 (-3.8A) None	0.59A	4jd6B-5tvjA: 61.2	4jd6B-5tvjA: 98.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4JD6_B_TOYB501_1 (ENHANCED INTRACELLULAR SURVIVAL PROTEIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	7 / 9	PHE A 24 ASP A 26 TRP A 36 SER A 83 TYR A 126 GLU A 203 GLU A 401	7LF A 502 ( 3.9A) 7LF A 502 (-3.5A) 7LF A 502 (-3.9A) 7LF A 502 (-3.5A) COA A 501 (-4.0A) None 7LF A 502 (-3.3A)	1.00A	4jd6B-5tvjA: 61.2	4jd6B-5tvjA: 98.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4JD6_B_TOYB501_1 (ENHANCED INTRACELLULAR SURVIVAL PROTEIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	7 / 9	PHE A 24 ASP A 26 TRP A 36 SER A 83 VAL A 85 GLU A 203 GLU A 401	7LF A 502 ( 3.9A) 7LF A 502 (-3.5A) 7LF A 502 (-3.9A) 7LF A 502 (-3.5A) COA A 501 (-3.8A) None 7LF A 502 (-3.3A)	0.68A	4jd6B-5tvjA: 61.2	4jd6B-5tvjA: 98.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9Q_B_9TPB601_1 (SERUM ALBUMIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 12	PRO A 302 ALA A 330 LEU A 356 LEU A 359 GLY A 362	None	1.22A	4l9qB-5tvjA: undetectable	4l9qB-5tvjA: 20.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QB9_E_PARE500_1 (ENHANCED INTRACELLULAR SURVIVAL PROTEIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 12	SER A 83 LEU A 118 SER A 121 TYR A 126 ASP A 292	7LF A 502 (-3.5A) COA A 501 ( 4.8A) COA A 501 ( 4.4A) COA A 501 (-4.0A) None	0.75A	4qb9E-5tvjA: 50.7	4qb9E-5tvjA: 60.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X1Y_B_LOCB502_1 (TUBULIN BETA CHAIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 12	LEU A 217 ALA A 255 MET A 262 ALA A 236 VAL A 238	None	0.97A	4x1yB-5tvjA: undetectable	4x1yB-5tvjA: 20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X1Y_D_LOCD502_2 (TUBULIN BETA CHAIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	6 / 12	LEU A 217 LEU A 259 MET A 262 ALA A 236 VAL A 238 ILE A 265	None	1.38A	4x1yD-5tvjA: undetectable	4x1yD-5tvjA: 20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X20_D_LOCD502_2 (TUBULIN BETA CHAIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	6 / 11	LEU A 217 LEU A 259 MET A 262 ALA A 236 VAL A 238 ILE A 265	None	1.41A	4x20D-5tvjA: undetectable	4x20D-5tvjA: 20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XI3_A_29SA601_1 (ESTROGEN RECEPTOR)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 12	THR A 135 ALA A 363 LEU A 369 LEU A 296 PRO A 72	None	1.20A	4xi3A-5tvjA: undetectable	4xi3A-5tvjA: 20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XI3_D_29SD601_1 (ESTROGEN RECEPTOR)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 12	THR A 135 ALA A 363 LEU A 369 LEU A 296 PRO A 72	None	1.20A	4xi3D-5tvjA: undetectable	4xi3D-5tvjA: 20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UXD_B_ZITB501_1 (MACROLIDE 2'-PHOSPHOTRANSFERAS E MPHH)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	5 / 12	ILE A 349 LEU A 331 ALA A 311 GLY A 336 TYR A 310	None	0.81A	5uxdB-5tvjA: undetectable	5uxdB-5tvjA: 25.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6D8P_A_ACTA816_0 (UNCHARACTERIZED PROTEIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	3 / 3	ARG A 227 ARG A 230 ASP A 211	None	0.86A	6d8pA-5tvjA: undetectable	6d8pA-5tvjA: 19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FGD_A_ACTA821_0 (GEPHYRIN)	5tvj	ENHANCED INTRACELLULAR SURVIVAL PROTEIN (Mycobacterium tuberculosis)	3 / 3	ARG A 297 PHE A 129 GLY A 130	None	0.79A	6fgdA-5tvjA: undetectable	6fgdA-5tvjA: 23.29

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1DZ8_A_CAMA503_0","CYTOCHROME P450-CAM","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"PHE A 402;THR A  79;LEU A  69;GLY A 188;THR A 135","None","1.47A","1dz8A-5tvjA:undetectable","1dz8A-5tvjA:23.54"],["1DZ8_B_CAMB502_0","CYTOCHROME P450-CAM","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"PHE A 402;THR A  79;LEU A  69;GLY A 188;THR A 135","None","1.49A","1dz8B-5tvjA:undetectable","1dz8B-5tvjA:23.54"],["1DZ9_B_CAMB502_0","CYTOCHROME P450-CAM","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"PHE A 402;THR A  79;LEU A  69;GLY A 188;THR A 135","None","1.46A","1dz9B-5tvjA:undetectable","1dz9B-5tvjA:23.54"],["1FK6_A_LNLA1201_1","NON-SPECIFIC LIPID TRANSFER PROTEIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"VAL A  71;ALA A 363;ALA A 134;LEU A 296;ALA A 116","None","1.00A","1fk6A-5tvjA:undetectable","1fk6A-5tvjA:12.74"],["1GTN_J_TRPJ81_0","TRP RNA-BINDING ATTENUATION PROTEIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",4,"SER A  23;ALA A  22;GLY A  15;ALA A  21","None","0.66A","1gtnI-5tvjA:undetectable;1gtnJ-5tvjA:undetectable","1gtnI-5tvjA:12.06;1gtnJ-5tvjA:12.06"],["1LQT_A_ACTA1871_0","FPRA","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",4,"PHE A  84;ALA A  20;PHE A  27;PHE A  17","7LF A 502 (-4.0A);None;None;None","1.16A","1lqtA-5tvjA:undetectable","1lqtA-5tvjA:25.25"],["1LQU_A_ACTA1428_0","FPRA","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",4,"PHE A  84;ALA A  20;PHE A  27;PHE A  17","7LF A 502 (-4.0A);None;None;None","1.17A","1lquA-5tvjA:undetectable","1lquA-5tvjA:25.25"],["1RBP_A_RTLA183_0","PLASMA RETINOL-BINDING PROTEIN PRECURSOR","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"ALA A 311;ALA A 391;ALA A 389;LEU A 382;GLN A 381","None","1.20A","1rbpA-5tvjA:undetectable","1rbpA-5tvjA:17.83"],["2JN3_A_JN3A131_1","FATTY ACID-BINDING PROTEIN, LIVER","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"THR A 398;VAL A 115;LEU A  77;THR A  79;PHE A 402","GOL A 503 (-3.9A);None;None;None;None","1.20A","2jn3A-5tvjA:undetectable","2jn3A-5tvjA:13.77"],["2OKC_B_SAMB500_1","TYPE I RESTRICTION ENZYME STYSJI M PROTEIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",4,"THR A 288;ARG A 286;ASP A 229;THR A 231","None","1.16A","2okcB-5tvjA:undetectable","2okcB-5tvjA:21.94"],["2OKC_B_SAMB500_1","TYPE I RESTRICTION ENZYME STYSJI M PROTEIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",4,"THR A 288;ARG A 286;THR A 231;ASP A 211","None","1.11A","2okcB-5tvjA:undetectable","2okcB-5tvjA:21.94"],["2QXS_A_RALA600_1","ESTROGEN RECEPTOR","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"THR A 135;ALA A 363;LEU A 369;LEU A 296;PRO A  72","None","1.15A","2qxsA-5tvjA:undetectable","2qxsA-5tvjA:20.24"],["2XN7_A_T44A1355_1","THYROXINE-BINDING GLOBULIN;THYROXINE-BINDING GLOBULIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"LEU A 331;LEU A 321;LEU A 356;LEU A 305;ARG A 308","None","1.15A","2xn7A-5tvjA:undetectable;2xn7B-5tvjA:undetectable","2xn7A-5tvjA:20.93;2xn7B-5tvjA:7.36"],["3G1U_D_ADND438_1","ADENOSYLHOMOCYSTEINASE","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"LEU A 190;THR A  79;THR A 398;LEU A 361;PHE A 402","None;None;GOL A 503 (-3.9A);None;None","1.27A","3g1uD-5tvjA:undetectable","3g1uD-5tvjA:22.36"],["3GWV_A_RFXA801_1","TRANSPORTER","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"LEU A 383;ARG A 385;GLN A 381;ILE A 349;PHE A 317","None","1.03A","3gwvA-5tvjA:undetectable","3gwvA-5tvjA:21.86"],["3WIP_G_ACHG301_0","ACETYLCHOLINE-BINDING PROTEIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",4,"TYR A 360;THR A  70;ARG A 183;LEU A 190","None; CL A 504 (-3.8A); CL A 504 (-3.9A);None","1.18A","3wipG-5tvjA:undetectable;3wipH-5tvjA:undetectable","3wipG-5tvjA:18.98;3wipH-5tvjA:18.98"],["4DTZ_B_LDPB501_1","CYTOCHROME P450 BM3 VARIANT 8C8","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",4,"PHE A 402;ALA A 399;LEU A 294;THR A 398","None;None;None;GOL A 503 (-3.9A)","1.11A","4dtzB-5tvjA:undetectable","4dtzB-5tvjA:21.51"],["4FGZ_B_CQAB302_0","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",4,"GLU A 180;ARG A 242;GLY A 189;ARG A 183","None;None; CL A 504 (-4.7A); CL A 504 (-3.9A)","1.02A","4fgzA-5tvjA:undetectable;4fgzB-5tvjA:undetectable","4fgzA-5tvjA:17.56;4fgzB-5tvjA:17.56"],["4FZV_A_SAMA401_0","PUTATIVE METHYLTRANSFERASE NSUN4","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"GLY A 160;GLY A 159;LEU A 218;GLY A 222;LEU A 252","None","1.08A","4fzvA-5tvjA:undetectable","4fzvA-5tvjA:21.22"],["4JD6_A_TOYA501_1","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",7,"PHE A  24;ASP A  26;ILE A  28;TRP A  36;SER A  83;TYR A 126;GLU A 203","7LF A 502 ( 3.9A);7LF A 502 (-3.5A);7LF A 502 (-4.1A);7LF A 502 (-3.9A);7LF A 502 (-3.5A);COA A 501 (-4.0A);None","0.93A","4jd6A-5tvjA:61.2","4jd6A-5tvjA:98.60"],["4JD6_A_TOYA501_1","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",7,"PHE A  24;ASP A  26;ILE A  28;TRP A  36;SER A  83;VAL A  85;GLU A 203","7LF A 502 ( 3.9A);7LF A 502 (-3.5A);7LF A 502 (-4.1A);7LF A 502 (-3.9A);7LF A 502 (-3.5A);COA A 501 (-3.8A);None","0.62A","4jd6A-5tvjA:61.2","4jd6A-5tvjA:98.60"],["4JD6_A_TOYA501_1","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",7,"PHE A  24;ASP A  26;TRP A  36;SER A  83;VAL A  85;GLU A 203;GLU A 401","7LF A 502 ( 3.9A);7LF A 502 (-3.5A);7LF A 502 (-3.9A);7LF A 502 (-3.5A);COA A 501 (-3.8A);None;7LF A 502 (-3.3A)","0.75A","4jd6A-5tvjA:61.2","4jd6A-5tvjA:98.60"],["4JD6_B_TOYB501_1","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",7,"PHE A  24;ASP A  26;ILE A  28;TRP A  36;SER A  83;TYR A 126;GLU A 203","7LF A 502 ( 3.9A);7LF A 502 (-3.5A);7LF A 502 (-4.1A);7LF A 502 (-3.9A);7LF A 502 (-3.5A);COA A 501 (-4.0A);None","0.90A","4jd6B-5tvjA:61.2","4jd6B-5tvjA:98.60"],["4JD6_B_TOYB501_1","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",7,"PHE A  24;ASP A  26;ILE A  28;TRP A  36;SER A  83;VAL A  85;GLU A 203","7LF A 502 ( 3.9A);7LF A 502 (-3.5A);7LF A 502 (-4.1A);7LF A 502 (-3.9A);7LF A 502 (-3.5A);COA A 501 (-3.8A);None","0.59A","4jd6B-5tvjA:61.2","4jd6B-5tvjA:98.60"],["4JD6_B_TOYB501_1","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",7,"PHE A  24;ASP A  26;TRP A  36;SER A  83;TYR A 126;GLU A 203;GLU A 401","7LF A 502 ( 3.9A);7LF A 502 (-3.5A);7LF A 502 (-3.9A);7LF A 502 (-3.5A);COA A 501 (-4.0A);None;7LF A 502 (-3.3A)","1.00A","4jd6B-5tvjA:61.2","4jd6B-5tvjA:98.60"],["4JD6_B_TOYB501_1","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",7,"PHE A  24;ASP A  26;TRP A  36;SER A  83;VAL A  85;GLU A 203;GLU A 401","7LF A 502 ( 3.9A);7LF A 502 (-3.5A);7LF A 502 (-3.9A);7LF A 502 (-3.5A);COA A 501 (-3.8A);None;7LF A 502 (-3.3A)","0.68A","4jd6B-5tvjA:61.2","4jd6B-5tvjA:98.60"],["4L9Q_B_9TPB601_1","SERUM ALBUMIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"PRO A 302;ALA A 330;LEU A 356;LEU A 359;GLY A 362","None","1.22A","4l9qB-5tvjA:undetectable","4l9qB-5tvjA:20.63"],["4QB9_E_PARE500_1","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"SER A  83;LEU A 118;SER A 121;TYR A 126;ASP A 292","7LF A 502 (-3.5A);COA A 501 ( 4.8A);COA A 501 ( 4.4A);COA A 501 (-4.0A);None","0.75A","4qb9E-5tvjA:50.7","4qb9E-5tvjA:60.42"],["4X1Y_B_LOCB502_1","TUBULIN BETA CHAIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"LEU A 217;ALA A 255;MET A 262;ALA A 236;VAL A 238","None","0.97A","4x1yB-5tvjA:undetectable","4x1yB-5tvjA:20.85"],["4X1Y_D_LOCD502_2","TUBULIN BETA CHAIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",6,"LEU A 217;LEU A 259;MET A 262;ALA A 236;VAL A 238;ILE A 265","None","1.38A","4x1yD-5tvjA:undetectable","4x1yD-5tvjA:20.85"],["4X20_D_LOCD502_2","TUBULIN BETA CHAIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",6,"LEU A 217;LEU A 259;MET A 262;ALA A 236;VAL A 238;ILE A 265","None","1.41A","4x20D-5tvjA:undetectable","4x20D-5tvjA:20.85"],["4XI3_A_29SA601_1","ESTROGEN RECEPTOR","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"THR A 135;ALA A 363;LEU A 369;LEU A 296;PRO A  72","None","1.20A","4xi3A-5tvjA:undetectable","4xi3A-5tvjA:20.09"],["4XI3_D_29SD601_1","ESTROGEN RECEPTOR","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"THR A 135;ALA A 363;LEU A 369;LEU A 296;PRO A  72","None","1.20A","4xi3D-5tvjA:undetectable","4xi3D-5tvjA:20.09"],["5UXD_B_ZITB501_1","MACROLIDE 2'-PHOSPHOTRANSFERASE MPHH","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",5,"ILE A 349;LEU A 331;ALA A 311;GLY A 336;TYR A 310","None","0.81A","5uxdB-5tvjA:undetectable","5uxdB-5tvjA:25.98"],["6D8P_A_ACTA816_0","UNCHARACTERIZED PROTEIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",3,"ARG A 227;ARG A 230;ASP A 211","None","0.86A","6d8pA-5tvjA:undetectable","6d8pA-5tvjA:19.57"],["6FGD_A_ACTA821_0","GEPHYRIN","5tvj","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","Mycobacterium tuberculosis",3,"ARG A 297;PHE A 129;GLY A 130","None","0.79A","6fgdA-5tvjA:undetectable","6fgdA-5tvjA:23.29"]]